Cyclopropylamine → HCID 57334041, compound
Reaction equation
[CH3:1][N:2]1[C:6]([CH2:7][O:8][C:9]2[CH:17]=[CH:16][C:12]([C:13]([OH:15])=O)=[CH:11][N:10]=2)=[C:5]([C:18]2[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=2)[N:4]=[N:3]1.[CH:24]1([NH2:27])[CH2:26][CH2:25]1>>[CH:24]1([NH:27][C:13](=[O:15])[C:12]2[CH:16]=[CH:17][C:9]([O:8][CH2:7][C:6]3[N:2]([CH3:1])[N:3]=[N:4][C:5]=3[C:18]3[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=3)=[N:10][CH:11]=2)[CH2:26][CH2:25]1Participants
3
Procedure
As described for example 2b, 6-(3-methyl-5-phenyl-3H-[1,2,3]triazol-4-ylmethoxy)-nicotinic acid (155 mg, 0.5 mmol) was converted, using cyclopropylamine instead of 4-aminotetrahydropyran, to the title compound (167 mg, 96%) which was obtained as a white solid. MS: m/e=350.3 [M+H]+.
Sources & evidence
- ORD record
- ord-b47628c9294e4778b0197c4a3a1cc276
- Source dataset
- uspto-grants-2014_06
- Patent number
- US08742097B2
Reaction notes
Loading…